Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.
about
Nephrotoxic effects of common and emerging drugs of abuse.Targeting cannabinoid signaling for peritoneal dialysis-induced oxidative stress and fibrosis.NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery.Reversal of diabetic nephropathy by a ketogenic diet.Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance.Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.Endocannabinoid signaling at the periphery: 50 years after THC.Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathyThe endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complicationsCannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell lineInhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic ratsThe novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity.Modulating the endocannabinoid system in human health and disease--successes and failuresRenal Protective Role of Xiexin Decoction with Multiple Active Ingredients Involves Inhibition of Inflammation through Downregulation of the Nuclear Factor-κB Pathway in Diabetic Rats.Role of the endocannabinoid system in diabetes and diabetic complications.The podocyte as a target for therapies--new and old.Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier.Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment.Marijuana Use and Estimated Glomerular Filtration Rate in Young Adults.Cannabinoids and the Kidney: Effects in Health and Disease.Elevated cannabinoid receptor 1 and G protein-coupled receptor 55 expression in proximal tubule cells and whole kidney exposed to diabetic conditions.Role for cannabinoid receptors in human proximal tubular hypertrophy.Synthetic marijuana and acute kidney injury: an unforeseen associationThe endocannabinoid system in renal cells: regulation of Na(+) transport by CB1 receptors through distinct cell signalling pathways.Synthetic cannabinoids and acute kidney injury.Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability.Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy.Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-Induced CKD.Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy.Relationship between G proteins coupled receptors and tight junctions.Synthetic cannabinoids in the kidneys.Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy.Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.Cannabinoid receptor 1 disturbance of PPARγ2 augments hyperglycemia induction of mesangial inflammation and fibrosis in renal glomeruli.Cannabinoid receptor 1 mediates high glucose-induced apoptosis via endoplasmic reticulum stress in primary cultured rat mesangial cells.
P2860
Q21558458-79463EB0-4393-4DA0-8B6A-0CCCD0E2D62CQ33655394-D16E789C-F022-4A79-867F-B49DF23D6DFFQ33816779-FDB40C0B-AA6E-415F-A17B-86D229874077Q33886222-5BCDA776-59E9-45F5-B220-4E6E39CA8825Q34290823-49B7C7CD-1E14-4E09-9E37-78BB513C0CD1Q34752048-7B27445F-A0AC-4DC3-89C4-B368B669538AQ35179985-B55CCAD8-35CB-45BB-AF92-E832EB368C5FQ35572176-DFF0CDCD-902C-465F-BB9B-62CF31A6124BQ35766956-162F1C0D-4E57-4B78-AC65-D9F0E4536417Q35951992-35F0408E-72D8-4BE0-9226-B06855774C54Q36032332-6B42E957-3D2C-4561-A835-CFE67BAAB054Q36159004-B00B4EF4-E403-440A-BA93-D44B667F7FFEQ36506869-59B10F81-A93A-48C8-BC81-E0CC529BBFEAQ36933683-34D945B3-9761-4C21-B362-5FC45A60BCDFQ37019804-6167BB9A-6BB2-4AAD-8E14-CC6E86D0CE27Q37085532-B97A6EF9-D32A-45FE-830C-54F86AEC57D1Q37951800-C7C72BCA-5D6F-4B9E-89A5-F6771D690ED3Q38220272-D91AFA8F-53C1-451A-BBB6-8944E030A4AFQ38255902-E9AF7523-6FAA-4AE2-90E1-07F84B44782EQ38398867-F7753BF5-7FB3-4AE0-81BC-85F9989C296FQ38651395-31BCA8C9-5BA6-4BD4-A794-C008B5C45176Q38924783-6B1B7809-DADD-436C-AC5D-A8A14307A7E3Q39609590-F32E465D-91F1-4647-ACDC-13BF1829E4B4Q39719706-19F015E3-BFED-4B8C-BC88-115F571BE379Q41295964-D2F94DF2-9926-4A7F-A6FD-01E6C62E2D99Q41766626-AA2914A2-476C-4B68-B499-78C5DD55EA74Q41963239-EC604551-2074-46EC-99F1-2A663CD96B1FQ47445806-22F6B6D9-1CC8-4C39-B3E6-00DFBD4D37BCQ47874226-C87E9917-C52A-4C7E-B1B2-9BDC85ACBB3DQ47985501-EEE18467-7B95-4AB0-A69C-9993D79467A5Q50116104-B2FF88DF-F7AC-4A6B-93B2-89E1492623C6Q50878765-1218B90F-A11E-4297-97B3-5563C19AE9C1Q51067641-AA2C3776-E9A0-4011-BA8D-A4C605CF9EEFQ51835187-76A036B1-B15F-4C4C-BA50-665A44D24093Q52649284-49B0D89E-03CA-422F-9A7F-741EF0923CFEQ54387514-2F09BE10-C1C0-4988-A41E-2D9FE4D0147D
P2860
Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cannabinoid receptor 1 blockad ...... rimental diabetic nephropathy.
@ast
Cannabinoid receptor 1 blockad ...... rimental diabetic nephropathy.
@en
type
label
Cannabinoid receptor 1 blockad ...... rimental diabetic nephropathy.
@ast
Cannabinoid receptor 1 blockad ...... rimental diabetic nephropathy.
@en
prefLabel
Cannabinoid receptor 1 blockad ...... rimental diabetic nephropathy.
@ast
Cannabinoid receptor 1 blockad ...... rimental diabetic nephropathy.
@en
P2093
P2860
P921
P356
P1433
P1476
Cannabinoid receptor 1 blockad ...... erimental diabetic nephropathy
@en
P2093
Alessandro Corbelli
Federica Barutta
Gabriella Gruden
Maria Pia Rastaldi
Paolo Cavallo Perin
Roberto Gambino
Silvia Pinach
Vincenzo Di Marzo
P2860
P304
P356
10.2337/DB09-1336
P407
P577
2010-01-12T00:00:00Z